Although several studies have suggested that abnormal expression of DCTN2 may be associated with tumorigenesis and tumour progression the exact role of DCTN2 in various cancers is not yet fully understood, and its potential connection with antitumor immune responses warrants further investigation. This evidence concerns the gene DCTN2 and neoplasm.